RENB Financial Statements

Balance sheet, income statement, cash flow, and dividends for Renovaro Biosciences Inc (RENB).


$258.13M Market Cap.

As of 10/11/2024 5:00 PM ET (MRY) • Disclaimer

RENB Market Cap. (MRY)


RENB Shares Outstanding (MRY)


RENB Assets (MRY)


Total Assets

$163.13M

Total Liabilities

$31.15M

Total Investments

$0

RENB Income (MRY)


Revenue

$0

Net Income

-$80.65M

Operating Expense

$81.64M

RENB Cash Flow (MRY)


CF Operations

-$10.97M

CF Investing

-$1.26M

CF Financing

$10.52M

RENB Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

RENB Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$163,129,450 (179.81%)

$58,300,796 (-31.11%)

$84,632,663 (-55.36%)

$189,605,225 (6.46%)

Assets Current

$1,997,643 (-22.13%)

$2,565,405 (-73.18%)

$9,565,138 (-54.23%)

$20,898,993 (133.74%)

Assets Non-Current

$161,131,807 (189.10%)

$55,735,391 (-25.75%)

$75,067,525 (-55.50%)

$168,706,232 (-0.27%)

Goodwill & Intangible Assets

$159,360,204 (193.53%)

$54,290,676 (-25.89%)

$73,255,268 (-56.01%)

$166,529,906 (-0.01%)

Shareholders Equity

$131,977,144 (183.81%)

$46,502,111 (-35.96%)

$72,618,848 (-58.42%)

$174,662,939 (5.05%)

Property Plant & Equipment Net

$1,751,754 (23.11%)

$1,422,974 (-18.39%)

$1,743,622 (-19.10%)

$2,155,342 (-13.16%)

Cash & Equivalents

$220,467 (-88.24%)

$1,874,480 (-79.56%)

$9,172,142 (-55.61%)

$20,664,410 (137.62%)

Accumulated Other Comprehensive Income

-$170,846 (-471.74%)

-$29,882 (1.82%)

-$30,436 (-180.93%)

-$10,834 (73.84%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$1,108,247 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$9,448,683 (78.38%)

$5,296,823 (277.84%)

$1,401,867 (337.32%)

$320,559 (-45.93%)

Accumulated Retained Earnings (Deficit)

-$324,679,425 (-33.05%)

-$244,029,253 (-19.42%)

-$204,345,197 (-124.77%)

-$90,911,805 (-41.63%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$3,786,938 (-32.30%)

$5,593,956 (-20.27%)

$7,016,483 (-4.03%)

$7,310,857 (-3.60%)

Debt Current

$2,944,549 (-38.89%)

$4,818,369 (231.47%)

$1,453,636 (397.12%)

$292,409 (7.79%)

Debt Non-Current

$842,389 (8.61%)

$775,587 (-86.06%)

$5,562,847 (-20.74%)

$7,018,448 (-4.02%)

Total Liabilities

$31,152,306 (164.03%)

$11,798,685 (-1.79%)

$12,013,815 (-19.60%)

$14,942,286 (26.31%)

Liabilities Current

$30,309,917 (174.97%)

$11,023,098 (70.88%)

$6,450,968 (242.06%)

$1,885,893 (41.29%)

Liabilities Non-Current

$842,389 (8.61%)

$775,587 (-86.06%)

$5,562,847 (-57.39%)

$13,056,393 (24.41%)

RENB Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$24,557,608 (60.32%)

$15,318,198 (6.90%)

$14,329,801 (89.60%)

$7,557,990 (6.14%)

Research & Development Expense

$2,708,829 (-34.97%)

$4,165,197 (-50.25%)

$8,372,800 (-46.74%)

$15,720,262 (234.88%)

Operating Expenses

$81,639,296 (111.74%)

$38,556,891 (-66.78%)

$116,079,191 (396.03%)

$23,401,787 (96.26%)

Interest Expense

$1,011,322 (74.26%)

$580,344 (55.65%)

$372,844 (-1.78%)

$379,608 (264.03%)

Income Tax Expense

$0 (0%)

$0 (0%)

$34 (100.03%)

-$125,276 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$80,650,172 (-103.23%)

-$39,684,056 (65.02%)

-$113,433,392 (-324.47%)

-$26,723,607 (-134.08%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$80,650,172 (-103.23%)

-$39,684,056 (65.02%)

-$113,433,392 (-324.47%)

-$26,723,607 (-134.08%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$80,650,172 (-103.23%)

-$39,684,056 (65.02%)

-$113,433,392 (-324.47%)

-$26,723,607 (-134.08%)

Weighted Average Shares

$96,248,090 (71.06%)

$56,265,362 (7.11%)

$52,528,024 (11.37%)

$47,167,262 (1.81%)

Weighted Average Shares Diluted

$96,248,090 (71.06%)

$56,265,362 (7.11%)

$52,528,024 (11.37%)

$47,167,262 (1.81%)

Earning Before Interest & Taxes (EBIT)

-$79,638,850 (-103.66%)

-$39,103,712 (65.41%)

-$113,060,514 (-327.14%)

-$26,469,275 (-133.99%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$81,639,296 (-111.74%)

-$38,556,891 (66.78%)

-$116,079,191 (-396.03%)

-$23,401,787 (-96.26%)

RENB Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$1,260,179 (-4132.48%)

-$29,774 (-477.46%)

-$5,156 (89.45%)

-$48,892 (73.49%)

Net Cash Flow from Financing

$10,517,455 (132.94%)

$4,515,056 (6.23%)

$4,250,464 (-86.96%)

$32,601,553 (352.80%)

Net Cash Flow from Operations

-$10,971,430 (6.82%)

-$11,774,549 (25.16%)

-$15,732,336 (23.67%)

-$20,610,723 (-97.05%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$1,654,013 (77.34%)

-$7,297,662 (36.50%)

-$11,492,268 (-196.02%)

$11,968,049 (433.76%)

Net Cash Flow - Business Acquisitions and Disposals

$65,851 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$1,255,600 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$70,430 (-136.55%)

-$29,774 (-477.46%)

-$5,156 (89.45%)

-$48,892 (73.49%)

Issuance (Repayment) of Debt Securities

$7,175,590 (739.67%)

-$1,121,767 (-100.01%)

-$560,848 (-2.60%)

-$546,651 (-108.82%)

Issuance (Purchase) of Equity Shares

$3,341,865 (-40.71%)

$5,636,823 (17.16%)

$4,811,312 (-85.49%)

$33,148,204 (3214.82%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$60,141 (816.39%)

-$8,395 (-60.21%)

-$5,240 (-120.07%)

$26,111 (118.39%)

Share Based Compensation

$4,673,129 (32.19%)

$3,535,051 (-35.62%)

$5,490,602 (280.03%)

$1,444,798 (40.45%)

Depreciation Amortization & Accretion

$121,859 (7.37%)

$113,496 (-8.17%)

$123,590 (0.05%)

$123,534 (-66.27%)

RENB Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-90.40% (-42.36%)

-63.50% (20.72%)

-80.10% (-397.52%)

-16.10% (-140.30%)

Return on Average Assets (ROAA)

-70.60% (-33.71%)

-52.80% (26.46%)

-71.80% (-378.67%)

-15.00% (-134.37%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

836.20% (-72.17%)

3004.90% (214.95%)

-2614.10% (-757.08%)

-305.00% (-77.84%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.08 (-161.03%)

-0.8 (10.74%)

-0.89 (89.75%)

-8.72 (48.22%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

1.96 (175.49%)

0.71 (-49.54%)

1.41 (3.46%)

1.36 (15.55%)

Debt to Equity Ratio (D/E)

0.24 (-7.09%)

0.25 (53.94%)

0.17 (91.86%)

0.09 (21.13%)

Earnings Per Share (EPS)

-0.84 (-18.31%)

-0.71 (67.13%)

-2.16 (-278.95%)

-0.57 (-128.00%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.12 (45.24%)

-0.21 (30.00%)

-0.3 (31.51%)

-0.44 (-90.43%)

Book Value Per Share (BVPS)

1.37 (65.98%)

0.83 (-40.23%)

1.38 (-62.68%)

3.7 (3.18%)

Tangible Assets Book Value Per Share (TABVPS)

0.04 (-45.07%)

0.07 (-67.28%)

0.22 (-55.62%)

0.49 (95.60%)

Enterprise Value Over EBIT (EV/EBIT)

-3 (-200.00%)

-1 (0.00%)

-1 (88.89%)

-9 (47.06%)

Enterprise Value Over EBITDA (EV/EBITDA)

-3.35 (-251.89%)

-0.95 (-9.30%)

-0.87 (90.45%)

-9.12 (48.10%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

0.07 (-71.67%)

0.23 (-84.29%)

1.48 (-86.62%)

11.08 (65.43%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$11,041,860 (6.46%)

-$11,804,323 (24.99%)

-$15,737,492 (23.82%)

-$20,659,615 (-94.10%)

Enterprise Value (EV)

$266,393,849 (617.81%)

$37,111,887 (-62.27%)

$98,358,551 (-59.07%)

$240,325,557 (24.92%)

Earnings Before Tax (EBT)

-$80,650,172 (-103.23%)

-$39,684,056 (65.02%)

-$113,433,358 (-322.49%)

-$26,848,883 (-135.18%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$79,516,991 (-103.94%)

-$38,990,216 (65.48%)

-$112,936,924 (-328.67%)

-$26,345,741 (-140.69%)

Invested Capital

-$22,974,200 (-597.56%)

-$3,293,502 (-218.87%)

$2,770,768 (-64.64%)

$7,835,873 (-14.02%)

Working Capital

-$28,312,274 (-234.75%)

-$8,457,693 (-371.59%)

$3,114,170 (-83.62%)

$19,013,100 (149.96%)

Tangible Asset Value

$3,769,246 (-6.01%)

$4,010,120 (-64.75%)

$11,377,395 (-50.69%)

$23,075,319 (99.60%)

Market Capitalization

$258,133,652 (681.67%)

$33,023,483 (-67.69%)

$102,193,436 (-56.98%)

$237,545,881 (21.35%)

Average Equity

$89,181,137 (42.77%)

$62,463,616 (-55.89%)

$141,613,990 (-14.58%)

$165,788,182 (-2.47%)

Average Assets

$114,199,929 (52.08%)

$75,093,936 (-52.47%)

$157,983,533 (-11.16%)

$177,830,380 (-0.87%)

Invested Capital Average

-$9,523,856 (-631.86%)

-$1,301,324 (-130.09%)

$4,324,970 (-50.17%)

$8,679,717 (31.56%)

Shares

147,504,944 (153.08%)

58,283,591 (10.07%)

52,949,967 (10.78%)

47,795,952 (2.79%)